assembly Bill A9634

2019-2020 Legislative Session

Relates to medication assisted treatment for substance use disorders

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (2)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Mar 11, 2020 reported referred to ways and means
Jan 28, 2020 referred to health

Co-Sponsors

view additional co-sponsors

A9634 (ACTIVE) - Details

See Senate Version of this Bill:
S7699
Law Section:
Social Services Law
Laws Affected:
Amd §§365-a & 364-j, Soc Serv L; amd §273, Pub Health L
Versions Introduced in 2021-2022 Legislative Session:
A2030, S649

A9634 (ACTIVE) - Summary

Relates to medication assisted treatment for substance abuse disorders; prohibits prior authorization.

A9634 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  9634

                          I N  A S S E M B L Y

                            January 28, 2020
                               ___________

Introduced by M. of A. L. ROSENTHAL, QUART, RICHARDSON, CARROLL, WEPRIN,
  SIMON, GOTTFRIED, HEVESI -- read once and referred to the Committee on
  Health

AN  ACT  to  amend the social services law and the public health law, in
  relation to medication for the treatment of substance use disorders

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Subdivision 2 of section 365-a of the social services law
is amended by adding a new paragraph (gg) to read as follows:
  (GG) ALL BUPRENORPHINE PRODUCTS, METHADONE OR LONG  ACTING  INJECTABLE
NALTREXONE  FOR  DETOXIFICATION  OR MAINTENANCE TREATMENT OF A SUBSTANCE
USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES-
SIONAL GUIDELINES FOR THE TREATMENT OF A SUBSTANCE USE DISORDER.    SUCH
MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI-
ZATION MANDATE.
  §  2. Subdivision 26-b of section 364-j of the social services law, as
added by section 4 of part B of chapter 69  of  the  laws  of  2016,  is
amended to read as follows:
  26-b. Managed care providers shall not require prior authorization for
[an  initial  or  renewal  prescription  for buprenorphine or injectable
naltrexone  for  detoxification  or  maintenance  treatment  of   opioid
addiction  unless  the prescription is for a non-preferred or non-formu-
lary form of the drug or as otherwise required by section 1927(k)(6)  of
the  Social  Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE OR LONG
ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT
OF A SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO  GENERALLY  ACCEPTED
NATIONAL  PROFESSIONAL  GUIDELINES  FOR THE TREATMENT OF A SUBSTANCE USE
DISORDER.
  § 3. Subdivision 10 of section 273 of the public health law, as  added
by  section 5 of part B of chapter 69 of the laws of 2016, is amended to
read as follows:
  10. Prior authorization shall not  be  required  for  [an  initial  or
renewal  prescription  for  buprenorphine  or  injectable naltrexone for
detoxification or maintenance treatment of opioid addiction  unless  the

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets